Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G C Jayson

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
European Journal of Gynaecological Oncology|July 13, 2007
Weekly paclitaxel in the treatment of recurrent ovarian carcinomaL Byrd, F C Thistlethwaite, A Clamp, et al.
Angiogenesis|August 11, 2004
Quantitative angiogenesis assays in vivo--a reviewJurjees Hasan, S D Shnyder, M Bibby, et al.
British Journal of Cancer|April 22, 2010
Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugsK Brookes, J Cummings, A Backen, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 16, 2005
Pre-operative plasma levels of vascular endothelial growth factor A, C and D in patients with colorectal cancerS E Duff, M Saunders, V McCredie, et al.
British Journal of Cancer|October 14, 2005
Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancerJ Hasan, N Ton, S Mullamitha, et al.
The Journal of Biological Chemistry|February 7, 1998
Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitroG C Jayson, M Lyon, C Paraskeva, et al.
International Journal of Cancer|July 2, 1999
Coordinated modulation of the fibroblast growth factor dual receptor mechanism during transformation from human colon adenoma to carcinomaG C Jayson, C Vives, C Paraskeva, et al.
ESMO Open|March 13, 2022
Plasma Tie2 trajectories identify vascular response criteria for VEGF inhibitors across advanced biliary tract, colorectal and ovarian cancersC Zhou, J O'Connor, A Backen, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|October 13, 2007
Lymphatic vessel density, microvessel density and lymphangiogenic growth factor expression in colorectal cancerS E Duff, M Jeziorska, S Kumar, et al.
British Journal of Cancer|September 22, 1998
The treatment of nephrotic syndrome caused by primary (light chain) amyloid with vincristine, doxorubicin and dexamethasoneA M Wardley, G C Jayson, D J Goldsmith, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
European Journal of Gynaecological Oncology|July 13, 2007
Weekly paclitaxel in the treatment of recurrent ovarian carcinomaL Byrd, F C Thistlethwaite, A Clamp, et al.
Angiogenesis|August 11, 2004
Quantitative angiogenesis assays in vivo--a reviewJurjees Hasan, S D Shnyder, M Bibby, et al.
British Journal of Cancer|April 22, 2010
Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugsK Brookes, J Cummings, A Backen, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 16, 2005
Pre-operative plasma levels of vascular endothelial growth factor A, C and D in patients with colorectal cancerS E Duff, M Saunders, V McCredie, et al.
British Journal of Cancer|October 14, 2005
Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancerJ Hasan, N Ton, S Mullamitha, et al.
The Journal of Biological Chemistry|February 7, 1998
Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitroG C Jayson, M Lyon, C Paraskeva, et al.
International Journal of Cancer|July 2, 1999
Coordinated modulation of the fibroblast growth factor dual receptor mechanism during transformation from human colon adenoma to carcinomaG C Jayson, C Vives, C Paraskeva, et al.
ESMO Open|March 13, 2022
Plasma Tie2 trajectories identify vascular response criteria for VEGF inhibitors across advanced biliary tract, colorectal and ovarian cancersC Zhou, J O'Connor, A Backen, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|October 13, 2007
Lymphatic vessel density, microvessel density and lymphangiogenic growth factor expression in colorectal cancerS E Duff, M Jeziorska, S Kumar, et al.
British Journal of Cancer|September 22, 1998
The treatment of nephrotic syndrome caused by primary (light chain) amyloid with vincristine, doxorubicin and dexamethasoneA M Wardley, G C Jayson, D J Goldsmith, et al.
Pageof 7